Because excess weight is closely linked to insulin resistance, fatty liver disease, sleep apnoea, cardiovascular disease, and progression to type 2 diabetes, weight loss achieved with GLP-1 therapy can have wide-ranging metabolic benefits even before diabetes develops
jaundice (yellowing of skin/eyes) Trulicity is not recommended for patients with severe gastrointestinal disease, including gastroparesis (delayed stomach emptying)
With Tirzepatide removed from the drug shortage list, compounded alternatives are unauthorized, urging providers to adopt safer, compliant options
For general immune support, 30-100 micrograms daily meets most people's needs
N., Tyshchuk I
Salve J, Pate S, Debnath K, Langade D (2019) Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized Placebo-controlled Clinical Study